ReviewJournal of inflammation research2022

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence.

Florenzo Iannone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.